|Previous Section||Index||Home Page|
Jane Kennedy: We are committed to modernising mental health services to provide patients with quick, easy access to high quality services and effective treatment and care, and to give people greater choice in the treatment and care they receive. Taken together, NHS and local authority expenditure on mental health has increased in real terms by almost £1.27 billion. This is a real increase in resources of over 26.6 per cent. in the period 19992000 to 200304.
We along with the National Institute for Mental Health in England are supporting local services in implementing our guidance called 'Organising and Delivering Psychological Therapies' in order to promote choice; and develop new ways of working.
Chlamydia screening in England began in April 2003 in 10 areas and was extended to a further 16 areas in April 2004. The 26 programmes cover25 per cent. of all primary care trusts and offers opportunistic screening to asymptomatic sexually active men and women under 25 years of age. National screening will begin in April 2006. We are currently on target for full implementation in 2007, as set out in the White Paper Choosing Health: Making Healthier choices easier" published in 2004, copies of which are available in the Library.
22 Nov 2005 : Column 1799W
Mr. Byrne: This report was commissioned by North West London strategic health authority and is for the SHA to consider and respond to in the first instance. However, its conclusions largely concur with a joint Department of Health, Treasury and National Audit Office report into the project which was published last year and which has been acted upon by the Department.
22. Mr. Hurd: To ask the Secretary of State for Health what the responsibilities of local authorities are in respect of the provision of rehabilitation services for blind and visually impaired people. 
Mr. Byrne: It is for local authorities to determine how best to provide services to meet the needs of individuals in their populations, in the light of local priorities. This includes assessment and provision of appropriate support and rehabilitation services for blind and partially sighted people.
Mr. Byrne: The Department has commissioned a number of research projects related to chronic fatigue syndrome and myalgic encephalomyelitis and details of these are available on the National Research Register, which can be accessed through the Department's research and development website [at www.dh.gov.uk/research].
Caroline Flint: We have developed new clinical roleslike nurse consultants and modern matrons and community matrons. We have introduced initiatives such as prescribing rights for nurses. We have provided support for new advanced nursing roles in all settings and funded thousands of nurses to take part in leadership programmes.
|Estimate cost (£) million|
Dr. Blackman-Woods: To ask the Secretary of State for Health when she expects the National Institute of Health and Clinical Excellence to publish its final guidance on the continued use of (a) donepezil, (b) rivastigmine and (c) galantamine to treat Alzheimer's disease. 
This is a matter for the National Institute for Health and Clinical Excellence (NICE). Information about NICE's current work programme is available on the NICE's website at: www.nice.org.uk. I
22 Nov 2005 : Column 1801W
understand that NICE's appraisal committee is due to meet later in December and NICE will conclude the appraisal in April 2006.
Mr. Burstow: To ask the Secretary of State for Healthwhat the (a) number of prescription items and(b) prescription expenditure has been for anti-depressant drugs in each year since 1984; and what the percentage change was between (i) 1984 and 1994, (ii)1994 and 2004 and (iii) 1984 and 2004. 
|Number of anti-depressant medicines prescribed on the NHS in England||Value of anti-depressant items prescribed on the NHS in England (£)|
|NHS anti-depressant medications in England: volume growth change||NHS anti-depressant medications in England: cost change|
|Next Section||Index||Home Page|